Archive | Articles RSS feed for this section

Counterpoints: Do Patients With Multiple Myeloma Need Maintenance Treatment?

April 13, 2015

0 Comments

By Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3 Multiple myeloma is an incurable disease, and patients who respond to treatment eventually relapse—which makes long-term maintenance therapy an appealing option. But is a treatment with an unclear effect on overall survival worth the side effects and financial cost? In this month’s […]

Continue reading...

Talking About Myeloma with Loved Ones

February 6, 2015

0 Comments

Do you feel the Love? The New Year is here. Perhaps you have been newly diagnosed? Whether a Myeloma warrior, or new to the world of MM, talking about the disease with loved ones can be difficult, at best. What is Multiple Myeloma anyway? It’s hard enough to understand the disease, let alone explain it! […]

Continue reading...

Counterpoints: To Transplant or Not To Transplant

April 10, 2014

0 Comments

More Is Not Better Claudia Andreu-Vieyra, Ph.D and James Berenson, M.D. Multiple myeloma (MM) is the most common primary malignancy of the bone marrow.1, The 5-year survival rate for MM patients has increased from 25% in 1975 to almost 40% due to newer and more effective drugs, such as the immunomodulatory agents (IMiDs) thalidomide and […]

Continue reading...